A Fytagoridis1, M Åström, K Wårdell, P Blomstedt. 1. Department of Pharmacology and Clinical Neuroscience, Neurosurgery, Umeå University, Umeå, Sweden. anders.fytagoridis@neuro.umu.se
Abstract
OBJECTIVE: The posterior subthalamic area (PSA) is an emerging but relatively unexplored target for DBS treatment of tremor. The aim of the study was to explore the area further by evaluating the spatial distribution and the characteristics of stimulation-induced side effects in this area. METHODS: Twenty-eight patients with essential tremor (ET) implanted with 33 DBS electrodes were evaluated concerning stimulation-induced side effects by testing each contact separately one year after surgery. The location of the side effects were plotted on axial slides of the Morel Stereotactic Atlas and a 3-dimensional model of the area for visualization was created. RESULTS: Visualization of the contacts eliciting stimulation-induced side effects demonstrated that identical responses can be elicited from various points in the PSA and its vicinity. The majority of contacts inducing muscular affection and cerebellar symptoms, including dysarthria, could not be attributed to an effect on the internal capsule. Paresthesias, affecting various body parts were elicited throughout the area without a clear somatotopic pattern. CONCLUSION: Stimulation-induced side effects in the PSA and its vicinity were difficult to attribute to certain anatomical areas as the same response was induced from various locations. Therefore, this study could not provide a meaningful somatotopic map with regard to stimulation-induced side effects in the PSA.
OBJECTIVE: The posterior subthalamic area (PSA) is an emerging but relatively unexplored target for DBS treatment of tremor. The aim of the study was to explore the area further by evaluating the spatial distribution and the characteristics of stimulation-induced side effects in this area. METHODS: Twenty-eight patients with essential tremor (ET) implanted with 33 DBS electrodes were evaluated concerning stimulation-induced side effects by testing each contact separately one year after surgery. The location of the side effects were plotted on axial slides of the Morel Stereotactic Atlas and a 3-dimensional model of the area for visualization was created. RESULTS: Visualization of the contacts eliciting stimulation-induced side effects demonstrated that identical responses can be elicited from various points in the PSA and its vicinity. The majority of contacts inducing muscular affection and cerebellar symptoms, including dysarthria, could not be attributed to an effect on the internal capsule. Paresthesias, affecting various body parts were elicited throughout the area without a clear somatotopic pattern. CONCLUSION: Stimulation-induced side effects in the PSA and its vicinity were difficult to attribute to certain anatomical areas as the same response was induced from various locations. Therefore, this study could not provide a meaningful somatotopic map with regard to stimulation-induced side effects in the PSA.
Authors: Edgar Peña; Simeng Zhang; Remi Patriat; Joshua E Aman; Jerrold L Vitek; Noam Harel; Matthew D Johnson Journal: J Neural Eng Date: 2018-09-13 Impact factor: 5.379
Authors: Till A Dembek; Michael T Barbe; Mattias Åström; Mauritius Hoevels; Veerle Visser-Vandewalle; Gereon R Fink; Lars Timmermann Journal: Neuroimage Clin Date: 2016-11-17 Impact factor: 4.881
Authors: Robert S Eisinger; Joshua Wong; Leonardo Almeida; Adolfo Ramirez-Zamora; Jackson N Cagle; Juan C Giugni; Bilal Ahmed; Alberto R Bona; Erin Monari; Aparna Wagle Shukla; Christopher W Hess; Justin D Hilliard; Kelly D Foote; Aysegul Gunduz; Michael S Okun; Daniel Martinez-Ramirez Journal: Mov Disord Clin Pract Date: 2017-11-27
Authors: Myung Ji Kim; Kyung Won Chang; So Hee Park; Won Seok Chang; Hyun Ho Jung; Jin Woo Chang Journal: Front Neurol Date: 2021-06-09 Impact factor: 4.003
Authors: Michael T Barbe; Jeremy Franklin; Daria Kraus; Paul Reker; Till A Dembek; Niels Allert; Jochen Wirths; Jürgen Voges; Lars Timmermann; Veerle Visser-Vandewalle Journal: Trials Date: 2016-09-29 Impact factor: 2.279